Partnerships With John Muir Health And Hartford Healthcare Will Open New Market Opportunities

Published
16 Sep 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$33.60
20.2% undervalued intrinsic discount
07 Aug
US$26.80
Loading
1Y
-12.7%
7D
20.8%

Author's Valuation

US$33.6

20.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 23%

Shared on23 Apr 25
Fair value Decreased 19%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Decreased 4.13%

AnalystConsensusTarget has decreased revenue growth from 10.5% to 8.6%, increased profit margin from 5.1% to 5.8% and decreased future PE multiple from 34.6x to 30.5x.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 7.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 24%

AnalystConsensusTarget has decreased revenue growth from 14.4% to 11.5%, increased profit margin from 4.6% to 5.1% and increased shares outstanding growth rate from 0.1% to 0.1%.